×
验证码:
换一张
Forgotten Password?
Stay signed in
Login With UMPASS
English
|
繁體
Login With UMPASS
Log In
ALL
ORCID
TI
AU
PY
SU
KW
TY
JN
DA
IN
PB
FP
ST
SM
Study Hall
Image search
Paste the image URL
Home
Faculties & Institutes
Scholars
Publications
Subjects
Statistics
News
Search in the results
Faculties & Institutes
Institute of Chi... [2]
Faculty of Healt... [1]
THE STATE KEY LA... [1]
Authors
HE CHENGWEI [2]
CHEN MEIWAN [1]
Document Type
Journal article [2]
Date Issued
2022 [1]
2021 [1]
Language
英語English [2]
Source Publication
Biochemical Phar... [1]
JOURNAL OF CANCE... [1]
Indexed By
SCIE [2]
Funding Organization
Funding Project
×
Knowledge Map
UM
Start a Submission
Submissions
Unclaimed
Claimed
Attach Fulltext
Bookmarks
Browse/Search Results:
1-2 of 2
Help
Selected(
0
)
Clear
Items/Page:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Sort:
Select
Issue Date Ascending
Issue Date Descending
Title Ascending
Title Descending
Author Ascending
Author Descending
WOS Cited Times Ascending
WOS Cited Times Descending
Submit date Ascending
Submit date Descending
Journal Impact Factor Ascending
Journal Impact Factor Descending
Glytabastan B, a coumestan isolated from Glycine tabacina, alleviated synovial inflammation, osteoclastogenesis and collagen-induced arthritis through inhibiting MAPK and PI3K/AKT pathways
Journal article
Tu, Yanbei, Tan, Lihua, Lu, Tao, Wang, Kai, Wang, Haiyong, Han, Bing, Zhao, Yuxin, Chen, Hanbin, Li, Yanfang, Chen, Haixia, Chen, Meiwan, He, Chengwei. Glytabastan B, a coumestan isolated from Glycine tabacina, alleviated synovial inflammation, osteoclastogenesis and collagen-induced arthritis through inhibiting MAPK and PI3K/AKT pathways[J]. Biochemical Pharmacology, 2022, 197, 114912.
Authors:
Tu, Yanbei
;
Tan, Lihua
;
Lu, Tao
;
Wang, Kai
;
Wang, Haiyong
; et al.
Favorite
|
TC[WOS]:
12
TC[Scopus]:
15
IF:
5.3
/
5.2
|
Submit date:2022/03/28
Glycine Tabacina
Glytabastan b
Inflammation
Network Pharmacology
Osteoclast
Rheumatoid Arthritis
Drug resistance of targeted therapy for advanced non-small cell lung cancer harbored EGFR mutation: from mechanism analysis to clinical strategy
Journal article
Yuxin Zhao, Haiyong Wang, Chengwei He. Drug resistance of targeted therapy for advanced non-small cell lung cancer harbored EGFR mutation: from mechanism analysis to clinical strategy[J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2021, 147(12), 3653-3664.
Authors:
Yuxin Zhao
;
Haiyong Wang
;
Chengwei He
Favorite
|
TC[WOS]:
20
TC[Scopus]:
19
IF:
2.7
/
3.1
|
Submit date:2021/12/08
Non-small Cell Lung Cancer
Targeted Therapy
Epidermal Growth Factor Receptor-tyrosine Kinase Inhibitor
Drug Resistance